Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
Sign Up to like & getrecommendations! Published in 2020 at "Gynecologic Oncology Reports"
DOI: 10.1016/j.gore.2020.100615
Abstract: Highlights • Chemotherapy resumption after convalescence from COVID-19 is safe and feasible.• No guidelines exist for resumption of chemotherapy in patients with COVID-19.• Cancer patients on chemotherapy may develop SARS-CoV-2 antibodies less frequently. read more here.
Keywords: chemotherapy; ovarian cancer; resumption ovarian; resumption ... See more keywords